Loading provider…
Loading provider…
Hematology & Oncology Physician in Daytona Beach, FL
NPI: 1306844360Primary Practice Location
HALIFAX HEALTH MEDICAL CENTER
303 N Clyde Morris Blvd, Daytona Beach, FL
Primary Employer
Hhcsi Halifax Family Health Center
halifax.org
HQ Phone
Get MD Ruby's Phone NumberMobile
Get MD Ruby's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
1998 - 2027
DC State Medical License
1999 - 2008

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
MedStart Georgetown University Hospital
Fellowship • Medical Oncology
1999 - 2002
Renaissance School of Medicine at Stony Brook University
stonybrook.edu
Medical School
Until 1996
University of Miami/Jackson Health System
Residency • Internal Medicine
1996 - 1999
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 187 | 283 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 116 | 129 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 83 | 208 |
| 4 | 99223Initial hospital inpatient care, typically 70 minutes per day | 34 | 37 |
| 5 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 33 | 66 |
Authors: Joseph Meschi, Amy Krie, Zubeena Mateen, Stephen Makoni, Rabih Fahed, Irfan Vaziri, Flavio Kruter
Journal: Breast J
Publication Date: 2019-06-11
Authors: Firozvi, Kashif, Deveras, Ruby Anne E, Kessler, Craig M
Journal: Am J Hematol
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, DRUG: Atezolizumab, DRUG: Fluorouracil, PROCEDURE: Computed Tomography, DRUG: Oxaliplatin, DRUG: Leucovorin Calcium
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Laboratory Biomarker Analysis, BIOLOGICAL: Pembrolizumab, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, RADIATION: Radiation Therapy, OTHER: Patient Observation
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, DRUG: Fluorouracil, DRUG: Veliparib, DRUG: Irinotecan Hydrochloride, DRUG: Leucovorin Calcium